Hussein Mohammad Hosny, Toraih Eman Ali, Reisner Adin, Shihabi Areej, Al-Quaryshi Zaid, Borchardt Jeffrey, Kandil Emad
Division of Endocrine and Oncologic Surgery, Department of Surgery, Tulane University School of Medicine, New Orleans, LA, USA.
Genetics Unit, Department of Histology and Cell Biology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Gland Surg. 2022 Apr;11(4):663-676. doi: 10.21037/gs-21-648.
Diabetes is a significant and prevalent medical condition associated with increased comorbidities, longer hospital length of stay, and higher healthcare costs. We aimed to assess the association between diabetes mellitus and postoperative outcomes following pancreatic surgeries.
Records for patients with major elective pancreatic surgeries were retrieved retrospectively from the Nationwide Readmission Database (2010-2014). Association of diabetic status with postoperative complications, in-hospital mortality, length of stay (LOS), readmission rate, and hospital costs were investigated. Logistic regression and decision tree analyses were employed to predict adverse outcomes.
A total of 8,401 patients who had pancreatic surgery were included. They were categorized according to their diabetic diagnosis. Results showed that diabetic patients had a higher risk of postoperative complications compared to non-diabetics (OR: 1.27, 95% CI: 1.08-1.49, P=0.003). Bleeding and renal complications were the most significant. Uncontrolled diabetes significantly required a longer hospital stay (9.17±4.28 8.03±4.96 days, P=0.001), and incurred higher hospital costs ($34,171.04±$20,846.61 $28,182.21±$24,070.27, P=0.001). After multivariate regression, no association was found with in-hospital mortality or readmission rates; however, diabetic patients' length of stay during readmission was increased at 30- and 90-day readmissions (P=0.004 and 0.007, respectively).
Among patients who underwent pancreatic surgery, those with diabetes had a higher rate of postoperative complications compared to non-diabetics. Additionally, diabetic patients had higher hospital charges and costs during primary admission. Initial analysis of patients with diabetes showed they had higher rates of 30- and 90-day readmissions, though this did not maintain significance after regression analysis. Exploring the mechanisms underlying this finding would aid in preventing postoperative complications and reducing healthcare costs.
糖尿病是一种严重且普遍的疾病,与合并症增加、住院时间延长及医疗费用升高相关。我们旨在评估糖尿病与胰腺手术后的术后结局之间的关联。
从全国再入院数据库(2010 - 2014年)中回顾性检索接受大型择期胰腺手术患者的记录。研究糖尿病状态与术后并发症、院内死亡率、住院时间(LOS)、再入院率及住院费用之间的关联。采用逻辑回归和决策树分析来预测不良结局。
共纳入8401例接受胰腺手术的患者。根据糖尿病诊断对他们进行分类。结果显示,与非糖尿病患者相比,糖尿病患者术后并发症风险更高(比值比:1.27,95%置信区间:1.08 - 1.49,P = 0.003)。出血和肾脏并发症最为显著。未控制的糖尿病显著需要更长的住院时间(9.17±4.28天对8.03±4.96天,P = 0.001),并产生更高的住院费用(34171.04美元±20846.61美元对28182.21美元±24070.27美元,P = 0.001)。多因素回归后,未发现与院内死亡率或再入院率相关;然而,糖尿病患者在30天和90天再入院时的住院时间增加(分别为P = 0.004和0.007)。
在接受胰腺手术的患者中,糖尿病患者术后并发症发生率高于非糖尿病患者。此外,糖尿病患者在初次住院期间的住院费用更高。对糖尿病患者的初步分析显示,他们的30天和90天再入院率较高,尽管回归分析后这一差异不再显著。探索这一发现背后的机制将有助于预防术后并发症并降低医疗费用。